Hospitals buy revolutionary technology
FOSUN International said Da Vinci robotic surgical systems had won contracts worth US$110 million from domestic hospitals as it showcased minimally invasive and other leading health care technologies during the on-going China International Import Expo in Shanghai.
Fosun Chairman Guo Guangchang said the company would continue to push forward multilateral collaboration with partners and stakeholders in various areas to help to improve health care in China.
“We’re eyeing at least 100 billion yuan (US$14.4 billion) of investment in R&D over the next 10 years and we would continue our in-house research efforts to drive research in fundamental science,” Guo told a forum on the sidelines of the CIIE.
“At the same time we are also seeking the best companies from around the globe as our partners.”
He said the company had invested about 4 billion yuan in the first six months of the year in technology initiatives and R&D projects, venture capital and incubation projects.
NASDAQ-listed Intuitive Surgical set up a joint venture with Fosun Pharmaceutical Group to research, develop, manufacture and sell innovative medical devices in 2016 after it first started to export surgical devices to China more than 13 years ago.
So far, 84 robotic systems from Intuitive have been installed in hospitals on China’s mainland and in Hong Kong and more than 100,000 surgeries have been completed using the surgery platform. Globally, more than 4,500 Da Vinci surgical platforms are in use.
“The further opening up of China’s economy would provide a favorable environment for players from various sectors in the health care industry to exchange ideas and collaborate with each other,” said Wang Jian, director of the National Health and Family Planning Commission’s International Health Exchange and Cooperation Center.